← Back to Search

Behavioral Intervention

Behavioral: Sit Less for Breast Cancer

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will see if reducing sitting time can improve quality of life for breast cancer survivors with some physical limitations.

Eligible Conditions
  • Breast Cancer
  • Sedentary Lifestyle

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Retention rate of enrolled participants
Secondary outcome measures
30-second Sit-to-Stand Test
4 meter walk test
Patient Reported Measurement Information System - Physical Function
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sit LessExperimental Treatment1 Intervention
The primary goal of the Sit Less arm is to reduce the total amount of time spent sitting each day and break up prolonged bouts of sitting.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral: Sit Less
2022
N/A
~30

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,386 Total Patients Enrolled
21 Trials studying Breast Cancer
7,327 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies to participate in this medical experiment?

"The clinicaltrials.gov portal denotes that this trial is not presently looking for patients, despite being initially posted on March 29th 2022 and last edited October 7th of the same year. However, there are over 2,500 other medical studies currently enrolling participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
RISE - Reduce Sitting Time Among Breast Cancer Survivors
Sheri Hartman 2022. "RISE - Reduce Sitting Time Among Breast Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05260723.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top